NO20090579L - Preparater med kontrollerte farmakokinetikker - Google Patents

Preparater med kontrollerte farmakokinetikker

Info

Publication number
NO20090579L
NO20090579L NO20090579A NO20090579A NO20090579L NO 20090579 L NO20090579 L NO 20090579L NO 20090579 A NO20090579 A NO 20090579A NO 20090579 A NO20090579 A NO 20090579A NO 20090579 L NO20090579 L NO 20090579L
Authority
NO
Norway
Prior art keywords
binder
effect
controls
food effect
food
Prior art date
Application number
NO20090579A
Other languages
English (en)
Norwegian (no)
Inventor
Ilan Zalit
Anat Sofer-Raz
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of NO20090579L publication Critical patent/NO20090579L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20090579A 2006-07-06 2009-02-05 Preparater med kontrollerte farmakokinetikker NO20090579L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81904106P 2006-07-06 2006-07-06
PCT/US2007/015593 WO2008005543A2 (en) 2006-07-06 2007-07-06 Compositions with controlled pharmacokinetics

Publications (1)

Publication Number Publication Date
NO20090579L true NO20090579L (no) 2009-02-05

Family

ID=38739986

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090579A NO20090579L (no) 2006-07-06 2009-02-05 Preparater med kontrollerte farmakokinetikker

Country Status (9)

Country Link
EP (1) EP2037894A2 (es)
JP (1) JP2009542693A (es)
KR (1) KR20090017668A (es)
CN (1) CN101484144A (es)
CA (1) CA2654529A1 (es)
IL (1) IL195542A0 (es)
MX (1) MX2008016573A (es)
NO (1) NO20090579L (es)
WO (1) WO2008005543A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0822782A2 (pt) * 2008-06-27 2015-09-29 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi composição farmacêutica que compreende rosuvastatina
US8977133B2 (en) 2012-05-31 2015-03-10 Corning Optical Communications LLC Distributed communications system employing free-space-optical link(S), and related components and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1414496B1 (en) * 2001-08-07 2010-10-20 Galephar M/F Pharmaceutical composition containing a combinaition of ppar-alpha, pravastatin and polyglycolized glyceride
US6669955B2 (en) * 2001-08-28 2003-12-30 Longwood Pharmaceutical Research, Inc. Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
KR20060085682A (ko) * 2003-10-10 2006-07-27 라이프사이클 파마 에이/에스 피브레이트 및 스타틴을 함유하는 고형 제제
ES2255426B1 (es) * 2004-10-19 2007-08-16 Gp Pharm, S.A. Formulacion farmaceutica que comprende microcapsulas de estatinas suspendidas en ester alquilicos de acidos grasos poliinsaturados (pufa).

Also Published As

Publication number Publication date
IL195542A0 (en) 2009-09-01
KR20090017668A (ko) 2009-02-18
WO2008005543A2 (en) 2008-01-10
WO2008005543A3 (en) 2008-02-14
MX2008016573A (es) 2009-01-28
EP2037894A2 (en) 2009-03-25
JP2009542693A (ja) 2009-12-03
CA2654529A1 (en) 2008-01-10
CN101484144A (zh) 2009-07-15

Similar Documents

Publication Publication Date Title
CR20110110A (es) Composicion farmaceutica
CY1118099T1 (el) Δισκια οξεικης ουλιπρισταλης
NO20071667L (no) Farmasoytisk preparat omfattende levetiracetam og fremgangsmate for fremstilling av preparatet
BRPI0720972B8 (pt) compostos análogos de ciclopamina e composições farmacêuticas compreendendo os referidos compostos
UA89315C2 (en) Butylbenzene phthalein intravenous emulsion
NO20090797L (no) Farmasoytiske blandinger omfattende kandesartan cileksetil
NO20075660L (no) Blanding for behandling av inflammatoriske sykdommer
NO20080284L (no) Cannabionoid aktiv farmasoytisk ingrediens for forbedrede doseringsformer
TN2009000180A1 (en) NOVEL 1,4-BENZOTHIEPIN-l,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF
NO20083104L (no) Fast preparat
WO2015017813A3 (en) Inhibitors of the farnesoid x receptor and uses in medicine
MX338895B (es) Emulsiones de aceite en agua estabilizadas que incluyen ingredientes activos agricolamente.
WO2009147170A3 (en) Drug combinations comprising a dgat inhibitor and a ppar-agonist
FR2983409B1 (fr) Comprime susceptible de lutter contre le detournement par voie injectable
ES2376043T3 (es) Derivados de indazol para el tratamiento de enfermedades inducidas por hsp90.
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
RS53759B1 (en) FUNGICIDE COMPOSITION AND PROCEDURE FOR PLANT DISEASE CONTROL
EA200800698A1 (ru) Способ стабилизации фармацевтических форм для введения, включающих микроорганизмы
NO20083836L (no) N-hydroksyakrylamidforbindelser
MX2012006921A (es) Composiciones que comprenden compuestos de lactona macrociclica y espirodioxepinoindoles.
WO2008004132A3 (en) The vapor-phase application of spinosyn for the control of pests, and formulations and products utilizing the same
NO20092763L (no) Isosorbid mononitrat derivater for behandling av tarmlidelser
NO20090579L (no) Preparater med kontrollerte farmakokinetikker
EA201070448A1 (ru) Новые композиции на основе таксоидов
WO2011014003A3 (en) (+)-3-hydroxymorphinan derivatives as neuroprotectants

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application